WFU

2018年5月25日 星期五

吳建東院長






講題




現職




學歷


  • 陽明大學傳統醫藥研究所  博士班 博士候選人
  • 中國醫藥大學  學士後中醫學系 醫學士


經歷


  • 華佗門八十代傳人
  • 台灣中醫家庭醫學醫學會  秘書長
  • 台北市立聯合醫院  中醫醫學部  住院醫師 總醫師


論文



  1. Wu CT, Tsai YT, Lai JN. Demographic and medication characteristics of traditional Chinese medicine users among colorectal cancer survivors: A nationwide database study in Taiwan. J Tradit Complement Med. 2016 Aug 6;7(2):188-194. doi: 10.1016/j.jtcme.2016.07.001. eCollection 2017 Apr. PubMed PMID: 28417089; PubMed Central PMCID: PMC5388081.   
  2. Hu YC, Wu CT, Lai JN, Tsai YT. Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study. J Ethnopharmacol. 2015 Jul 1;169:356-62. doi: 10.1016/j.jep.2015.04.028. Epub 2015 Apr 28. PubMed PMID: 25934515.   
  3. Hsu WL, Tsai YT, Wu CT, Lai JN. The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study. Evid Based Complement Alternat Med. 2015;2015:385204. doi: 10.1155/2015/385204. Epub 2015 Mar 1. PubMed PMID: 25815031; PubMed Central PMCID: PMC4359861.   
  4. Lin SK, Tsai YT, Lai JN, Wu CT. Demographic and medication characteristics of  traditional Chinese medicine users among dementia patients in Taiwan: a nationwide database study. J Ethnopharmacol. 2015 Feb 23;161:108-15. doi: 10.1016/j.jep.2014.12.015. Epub 2014 Dec 17. PubMed PMID: 25527314.   
  5. Wu CT, Lai JN, Tsai YT. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study. PLoS One. 2014 Dec 8;9(12):e113887. doi: 10.1371/journal.pone.0113887. eCollection 2014. PubMed PMID: 25485843; PubMed Central PMCID: PMC4259471.   
  6. Hsu PC, Tsai YT, Lai JN, Wu CT, Lin SK, Huang CY. Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study. J Ethnopharmacol. 2014 Oct 28;156:358-64. doi: 10.1016/j.jep.2014.08.029.  Epub 2014 Aug 29. PubMed PMID: 25178949.   
  7. Tsai YT, Lai JN, Wu CT. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study. J Ethnopharmacol. 2014 Sep 11;155(2):1256-62. doi: 10.1016/j.jep.2014.07.008. Epub 2014 Jul 15. PubMed PMID: 25048609.   
  8. Tsai YT, Lai JN, Wu CT, Lin SK. Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study. Evid Based Complement Alternat Med. 2014;2014:683570. doi: 10.1155/2014/683570. Epub 2014 May 29. PubMed PMID: 24987432; PubMed Central PMCID: PMC4058844.   
  9. Wu CT, Tzeng JN, Lai JN, Tsan SH, Wang JD. Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007. Chin Med. 2012 Oct 16;7(1):22. doi: 10.1186/1749-8546-7-22. PubMed PMID: 23072740; PubMed Central PMCID: PMC3507719.   
  10. Fang RC, Tsai YT, Lai JN, Yeh CH, Wu CT. The traditional chinese medicine prescription pattern of endometriosis patients in taiwan: a population-based study. Evid Based Complement Alternat Med. 2012;2012:591391. doi: 10.1155/2012/591391. Epub 2012 Sep 26. PubMed PMID: 23056141; PubMed Central PMCID: PMC3463977.   
  11. Lai JN, Wu CT, Wang JD. Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study. Evid Based Complement Alternat Med. 2012;2012:891893. doi: 10.1155/2012/891893. Epub 2012 May 28. PubMed PMID: 22685488; PubMed Central PMCID: PMC3368194.   
  12. Lai JN, Wu CT, Chen PC, Huang CS, Chow SN, Wang JD. Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008. PLoS One. 2011;6(10):e25183. doi: 10.1371/journal.pone.0025183. Epub 2011 Oct 6. PubMed PMID: 21998640; PubMed Central PMCID: PMC3188542.